READ MORE
Bionical Emas and Pharma Resources Announce Exclusive Global Clinical Trial Supply Partnership
READ MORE
Bionical Emas Earns 'B' Rating from the Carbon Disclosure Project, and Reinforces Commitment to Sustainability
READ MORE
Navigating data collection under Early Access Programs
READ MORE
Charity of the Year 2025 - RareQoL
READ MORE
Becarus Publishing: Innovative approaches to real-world data collection in UK Early Access Programs
READ MORE
Bionical Emas sells EMAS Pharma to Kester Capital following strategic review
READ MORE
Kester Capital backs experienced management team in acquiring EMAS Pharma
READ MORE
Bionical Emas is recognized as one of the UK’s Best Workplaces in BioPharma™!
READ MORE
Charity of the Year 2024 – The Dream Factory
READ MORE
The Guardian - Partnering with patients on their rare disease journey
READ MORE
Women in Healthcare - PharmaTimes May 2023
READ MORE
The Guardian - Inviting patients as equal partners in the drug development process